Canine atopic dermatitis is a chronic, relapsing inflammatory skin condition affecting up to 10% of dogs, causing intense itching and secondary infections that substantially reduce quality of life if inadequately managed.
Chronic pruritus is profoundly welfare-impairing. Dogs with poorly controlled atopic dermatitis experience relentless itch that drives compulsive self-trauma, disrupts sleep, and alters social behaviour. Secondary bacterial and yeast infections cause pain in addition to itch, compounding suffering. Many dogs are undertreated because owners underestimate the severity of itch-related suffering or do not seek specialist referral. Veterinary dermatology referral enables allergen identification through intradermal or serum testing, enabling specific immunotherapy that can achieve lasting improvement. Newer targeted therapeutics including monoclonal antibodies against interleukin-31 provide rapid itch relief with excellent safety profiles. Managing atopic dermatitis as the chronic welfare condition it is — requiring long-term monitoring and treatment adjustment — is essential for affected dogs.